CLINICAL_TRIALS
trial_result
· 2009-06-16
Clinical Trial Update: A Study of Fabrazyme in Pediatric Patients With Fabry Disease [Phase 2]
Summary
This clinical trial update summarizes Phase 2 results from a pediatric study of Fabrazyme in patients with Fabry disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-06-16